IMERYS (EPA:NK) - Imerys - Number of outstanding shares and voting rights as of 30 April 2021
Transparency directive : regulatory news
04/05/2021 17:50
Click here to download pdf version
INFORMATION4 May 2021
Number of outstanding shares and voting rights as of 30 April 2021
published pursuant to the provisions of article L. 233-8-II of the French Code
de Commerce and articles 221-1 et seq. and 223-16 of the AMF General
Regulations
30 April 2021
Total number of outstanding shares 84,940,955
Total number of theoretical voting rights determined
on all the shares making up the share capital,
including those without voting rights (*) 132,326,813
Total number of net voting rights 132,111,859
(*) Treasury shares
The world leader in mineral-based specialty solutions for industry with EUR4.4
billion in revenue and 16,300 employees in 2019. Imerys delivers high
value-added, functional solutions to a great number of sectors, from processing
industries to consumer goods. The Group draws on its understanding of
applications, technological knowledge and expertise in material science to
deliver solutions by bene?ciating its mineral resources, synthetic minerals
and formulations. Imerys' solutions contribute essential properties to
customers' products and their performance, including heat resistance, hardness,
conductivity, opacity, durability, purity, lightness, ?ltration, absorption
and water repellency. Imerys is determined to develop responsibly, in
particular by fostering the emergence of environmentally-friendly products and
processes.
More comprehensive information about Imerys may be obtained from its website
(www.imerys.com) under Regulated Information, particularly in its Universal
Registration Document ?led with Autorité des marchés ?nanciers on
March 24, 2020 under number D.20-0165 (also available from the Autorité des
marchés ?nanciers website, www.amf-france.org). Imerys draws the attention
of investors to chapter 2, "Risk Factors and Internal Control" of its Universal
Registration Document.
Disclaimer: This document contains projections and other forward-looking
statements. Investors should be aware that such projections and forward-looking
statements are subject to various risks and uncertainties (many of which are
di?cult to predict and generally beyond the control of Imerys) that could
cause actual results and developments to di?er materially from those
expressed or implied
Investor Relations
Vincent Gouley
+ 33 (0)1 49 55 64 69
?nance@imerys.com
Press Contact
Claire Lauvernier
+33 (0)1 49 55 66 65
IMERYS's latest news
11/04/2024 18:00
05/04/2024 17:55
04/04/2024 17:55
28/03/2024 08:45
26/03/2024 19:40
08/03/2024 18:15
26/02/2024 18:00
21/02/2024 18:07
31/01/2024 17:45
21/12/2023 18:00
Other stories
16/04/2024 19:28
16/04/2024 17:35
16/04/2024 18:00
16/04/2024 12:52
16/04/2024 17:29
16/04/2024 10:49
16/04/2024 08:04
16/04/2024 12:32
16/04/2024 17:50
16/04/2024 15:07
16/04/2024 16:25
16/04/2024 18:21
16/04/2024 12:36
16/04/2024 13:05
16/04/2024 18:36
16/04/2024 15:05
16/04/2024 17:33
16/04/2024 07:21
16/04/2024 01:00
15/04/2024 23:59
16/04/2024 12:30
16/04/2024 14:00
16/04/2024 16:44
16/04/2024 11:39
16/04/2024 16:18
16/04/2024 12:51
16/04/2024 15:28
16/04/2024 19:09
16/04/2024 18:15
16/04/2024 18:16
16/04/2024 18:43
16/04/2024 07:20
15/04/2024 07:00
15/04/2024 22:37
16/04/2024 12:32
15/04/2024 16:45
16/04/2024 09:18
16/04/2024 12:21